 |
市場調查報告書
商品編碼
1887810
尼古拉斯霍爾的CHC年鑑（2026）Nicholas Hall's CHC YearBook 2026 |
||||||
價格
《CHC年鑑（2026）》提供了全球CHC產業最新、最全面的資訊。它包含了專家分析，並涵蓋了截至2025年底的完整數據，這些數據均來自Nicholas Hall獨一無二且極具價值的“DB6全球CHC資料庫”，這是世界上唯一的專業CHC資料庫。
目錄
CHC市場定義
第1章：世界概覽
- 世界概覽
- 競爭格局
- 轉變
- 品牌與創新
- 零售
- 前景
第2章 區域概覽
- 北美洲
- 東亞和東南亞
- 西歐
- 中歐/東歐
- 拉丁美洲
- 日本
- 印度半島
- 澳大拉西亞
第3章 主要市場
- 美國
- 中國
- 俄羅斯
- 德國
- 日本
- 義大利
- 法國
- 巴西
- 印度
- 波蘭
- 英國
- 墨西哥
- 加拿大
- 澳洲
- 西班牙
第4章：類別評論
- 止痛藥
- 咳嗽、感冒、過敏
- 消化器官系統
- 維生素、礦物質、補充劑
- 皮膚科藥物
- Lifestyle CHC
第5章主要企業
- Haleon
- Kenvue
- Bayer
- Opella
- P&G
- Reckitt
- China Resources 999
- Taisho
- Unilever
- Otsuka
- Bausch Health
- Abbott
- Stada
- Teva
- Nestle
- Perrigo
- Hypera Pharma
- Cooper Consumer Health
- Prestige Consumer Healthcare
- Dong-e E-jiao Group
第6章併購
第7章：主要品牌
- 維克斯
- Tylenol
- 自然造物
- Voltaren
- 阿德維爾
- Panadol
- 中心
- 東阿惹
- 妮可萊特
- 穆希內克斯
- 大廳
- 第999章 槍茂林
- 神經藥
- 多里普蘭
- 使立消
- Electrolit
- 西替利嗪
- 半胱胺酸
- 虎牌一腳
- Yunnan Baiyao
- 卡拉特
- 奧利
- 阿萊格拉
- 開瑞坦
- 大自然的饋贈
第8章：專題討論
- 在營養補充品領域，思維敏捷性和大腦健康仍然展現出令人鼓舞的跡象。
- 使用 GLP-1 為 CHC 球員帶來機會
- 數位行銷策略仍在不斷發展。
- 促進治療與健康維護之間的過渡與治療系統及其環境密切相關。
第9章：Rx-OTC 開關
- 概述
- 西歐
- 北美洲
- 日本
- 澳大拉西亞
- 新興市場
- 大型開關
- 阿萊格拉
- 阿斯泰普羅
- Celebrex緩解
- 達芙文
- 迪米斯塔
- ellaOne
- 弗羅納斯/弗里克斯納斯
- 福米格蘭、德阿米格倫、諾米格倫
- 哈娜，洛維瑪
- Loxonin S
- 馬羅夫保護
- 米拉克斯
- 納爾坎
- 納薩科特
- Nexium 24HR
- 奧皮爾
- 帕塔代
- Plan B、Norlevo、Postinol、Levonel
- Prevacid 24HR
- Silvasta、MaxOn Active/Tadalafil MaxOn、Viagra Connect、Cialis
- Voltaren
- 西札爾
- 西替利嗪
第10章：新產品開發與創新
- 止痛藥
- 咳嗽、感冒、過敏
- 消化器官系統
- 維生素、礦物質、補充劑
- 皮膚科藥物
- Lifestyle CHC
第11章 全球零售
第12章 公司所有權
第13章：品牌與行銷人員
第14章 製造商協會
第15章詞彙表
CHC YearBook 2026 gives you the most up-to-date and fully-informed picture of the CHC industry around the world, featuring expert analysis and incorporating full year-end 2025 data from the only dedicated worldwide CHC database, Nicholas Hall’s unique and invaluable DB6 Global CHC Database.
Table of Contents
CHC Market Definition
1. Global Review
- World Overview
- Competitive Landscape
- Switch
- Brands & Innovation
- Retailing
- Outlook
2. Regional Review
- North America
- East & South East Asia
- Western Europe
- Central & Eastern Europe
- Latin America
- Japan
- Indian Subcontinent
- Australasia
3. Leading Markets
- USA
- China
- Russia
- Germany
- Japan
- Italy
- France
- Brazil
- India
- Poland
- UK
- Mexico
- Canada
- Australia
- Spain
4. Category Review
- Analgesics
- Cough, cold & allergy
- Gastrointestinals
- Vitamins, minerals & supplements
- Dermatologicals
- Lifestyle CHC
5. Leading Companies
- Haleon
- Kenvue
- Bayer
- Opella
- P&G
- Reckitt
- China Resources 999
- Taisho
- Unilever
- Otsuka
- Bausch Health
- Abbott
- Stada
- Teva
- Nestle
- Perrigo
- Hypera Pharma
- Cooper Consumer Health
- Prestige Consumer Healthcare
- Dong-e E-jiao Group
6. Mergers & Acquisitions
7. Leading Brands
- Vicks
- Tylenol
- Nature Made
- Voltaren
- Advil
- Panadol
- Centrum
- Dong-e E-jiao
- Nicorette
- Mucinex
- Halls
- 999 Gan Mao Ling
- Nurofen
- Doliprane
- Strepsils
- Electrolit
- Zyrtec
- Systane
- Fupai E-Jiao
- Yunnan Baiyao
- Caltrate
- Olly
- Allegra
- Claritin
- Nature’s Bounty
8. Hot Topics
- Mental acuity and brain health remain bright spots in supplementation
- GLP-1 usage offers opportunities for CHC players
- Digital marketing strategies continue to evolve
- Regimen and adjacencies drive shift from treatment to health maintenance
9. Rx-to-OTC Switch
- Overview
- Western Europe
- North America
- Japan
- Australasia
- Emerging markets
- The Big Switches
- Allegra
- Astepro
- Celebrex Relief
- Differin
- Dymista
- ellaOne
- Flonase / Flixonase
- Formigran, Dezamigren, Nomigren
- Hana, Lovima
- Loxonin S
- Maloff Protect
- MiraLAX
- Narcan
- Nasacort
- Nexium 24HR
- Opill
- Pataday
- Plan B, NorLevo, Postinor, Levonelle
- Prevacid 24HR
- Silvasta, MaxOn Active / Tadalafil MaxOn, Viagra Connect, Cialis
- Voltaren
- Xyzal
- Zyrtec
10. New Product Development & Innovation
- Analgesics
- Cough, Cold & Allergy
- Gastrointestinals
- Vitamins, Minerals & Supplements
- Dermatologicals
- Lifestyle CHC
11. Global Retailing
12. Company Ownership
13. Brands & Marketers
14. Manufacturers’ Associations
15. Glossary
Charts
- Chart 1: Global CHC sales by region 2025
- Chart 2: Global CHC sales by category 2025
- Chart 3: Global CHC forecasts by region
- Chart 4: Global CHC forecasts by category
- Chart 5: North America CHC market by category 2025
- Chart 6: North America leading CHC marketers & brands 2025
- Chart 7: E&SE Asia CHC market by category 2025
- Chart 8: E&SE Asia leading CHC marketers & brands 2025
- Chart 9: Western Europe CHC market by category 2025
- Chart 10: Western Europe leading CHC marketers & brands 2025
- Chart 11: C&E Europe CHC market by category 2025
- Chart 12: C&E Europe leading CHC marketers & brands 2025
- Chart 13: Latin America CHC market by category 2025
- Chart 14: Latin America leading CHC marketers & brands 2025
- Chart 15: Japan CHC market by category 2025
- Chart 16: Japan leading CHC marketers & brands 2025
- Chart 17: Indian Subcontinent CHC market by category 2025
- Chart 18: Indian Subcontinent leading CHC marketers & brands 2025
- Chart 19: Australasia CHC market by category 2025
- Chart 20: Australasia leading CHC marketers & brands 2025
- Chart 21: Global leading 15 CHC markets 2025
- Chart 22: USA CHC market by category 2025
- Chart 23: USA leading CHC marketers & brands 2025
- Chart 24: China CHC market by category 2025
- Chart 25: China leading CHC marketers & brands 2025
- Chart 26: Russia CHC market by category 2025
- Chart 27: Russia leading CHC marketers & brands 2025
- Chart 28: Germany CHC market by category 2025
- Chart 29: Germany leading CHC marketers & brands 2025
- Chart 30: Japan CHC market by category 2025
- Chart 31: Japan leading CHC marketers & brands 2025
- Chart 32: Italy CHC market by category 2025
- Chart 33: Italy leading CHC marketers & brands 2025
- Chart 34: France CHC market by category 2025
- Chart 35: France leading CHC marketers & brands 2025
- Chart 36: Brazil CHC market by category 2025
- Chart 37: Brazil leading CHC marketers & brands 2025
- Chart 38: India CHC market by category 2025
- Chart 39: India leading CHC marketers & brands 2025
- Chart 40: Poland CHC market by category 2025
- Chart 41: Poland leading CHC marketers & brands 2025
- Chart 42: UK CHC market by category 2025
- Chart 43: UK leading CHC marketers & brands 2025
- Chart 44: Mexico CHC market by category 2025
- Chart 45: Mexico leading CHC marketers & brands 2025
- Chart 46: Canada CHC market by category 2025
- Chart 47: Canada leading CHC marketers & brands 2025
- Chart 48: Australia CHC market by category 2025
- Chart 49: Australia leading CHC marketers & brands 2025
- Chart 50: Spain CHC market by category 2025
- Chart 51: Spain leading CHC marketers & brands 2025
- Chart 52: Global CHC analgesics category split 2025
- Chart 53: Leading analgesic brands 2025
- Chart 54: Global CHC CCA category split 2025
- Chart 55: Leading CCA brands 2025
- Chart 56: Global CHC GIs category split 2025
- Chart 57: Leading GI brands 2025
- Chart 58: Global CHC VMS category split 2025
- Chart 59: Leading VMS brands 2025
- Chart 60: Global CHC dermatologicals category split 2025
- Chart 61: Leading dermatological brands 2025
- Chart 62: Global lifestyle CHC category split 2025
- Chart 63: Leading lifestyle CHC brands 2025
- Chart 64: Top 250 CHC marketers 2025
- Chart 65: CHC merger, acquisition, alliance & joint-venture activity 2021-2026
- Chart 66: Multiples paid for CHC acquisitions 2022-2026
- Chart 67: Leading CHC brands 2025
- Chart 68: Legal status of ingredients in selected world markets
- Chart 69: Legal status of ingredients in selected European markets (I)
- Chart 70: Legal status of ingredients in selected European markets (II)
- Chart 71: Big Switches global CHC sales 2025
- Chart 72: Company Ownership Index
- Chart 73: Brands & Marketers Index
